{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:53:09Z","timestamp":1793116389512,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02166-8","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:54:09Z","timestamp":1778576049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Natural phenolic compounds as modulators of radiation response in hepatocellular carcinoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Amirhossein","family":"Imani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh B.","family":"Rassouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"10504","key":"2166_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","volume":"406","author":"SL Chan","year":"2025","unstructured":"Chan SL, Sun H-C, Xu Y, Zeng H, El-Serag HB, Lee JM, et al. The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment. Lancet. 2025;406(10504):731\u201378.","journal-title":"Lancet"},{"issue":"3","key":"2166_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"7","key":"2166_CR3","doi-asserted-by":"publisher","first-page":"e2421019","DOI":"10.1001\/jamanetworkopen.2024.21019","volume":"7","author":"LA Rodriguez","year":"2024","unstructured":"Rodriguez LA, Schmittdiel JA, Liu L, Macdonald BA, Balasubramanian S, Chai KP, et al. Hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease. JAMA Netw Open. 2024;7(7):e2421019\u2013e.","journal-title":"JAMA Netw Open"},{"key":"2166_CR4","doi-asserted-by":"crossref","unstructured":"Amin N, Anwar J, Sulaiman A, Naumova NN, Anwar N. Hepatocellular Carcinoma: A Comprehensive Review. Diseases. 2025;13(7):207.","DOI":"10.3390\/diseases13070207"},{"key":"2166_CR5","volume-title":"Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians","author":"D Moris","year":"2025","unstructured":"Moris D, Martinino A, Schiltz S, Allen PJ, Barbas A, Sudan D, et al. Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians. CA: A Cancer Journal for Clinicians; 2025."},{"issue":"1","key":"2166_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.17998\/jlc.2024.02.26","volume":"24","author":"D Kim","year":"2024","unstructured":"Kim D, Kim J-S. Current perspectives on radiotherapy in hepatocellular carcinoma management: a comprehensive review. J liver cancer. 2024;24(1):33\u201346.","journal-title":"J liver cancer"},{"issue":"2","key":"2166_CR7","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.3390\/curroncol30020190","volume":"30","author":"Y Matsuo","year":"2023","unstructured":"Matsuo Y. Stereotactic body radiotherapy for hepatocellular carcinoma: a brief overview. Curr Oncol. 2023;30(2):2493\u2013500.","journal-title":"Curr Oncol"},{"issue":"5","key":"2166_CR8","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3390\/ijms26051839","volume":"26","author":"J Wu","year":"2025","unstructured":"Wu J, Zhao X, Ren B, Duan X, Sun J. Radioresistance in Hepatocellular Carcinoma: Biological Bases and Therapeutic Implications. Int J Mol Sci. 2025;26(5):1839.","journal-title":"Int J Mol Sci"},{"key":"2166_CR9","doi-asserted-by":"crossref","unstructured":"Yang J, Chen R. Radiosensitization Strategies for Hepatocellular Carcinoma: Mechanisms, Therapeutic Advances, and Clinical Perspectives. Crit Rev Oncol\/Hematol. 2025:104773.","DOI":"10.1016\/j.critrevonc.2025.104773"},{"issue":"5","key":"2166_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/15384101.2022.2131163","volume":"22","author":"YJ Zhou","year":"2023","unstructured":"Zhou YJ, Tang Y, Liu SJ, Zeng PH, Qu L, Jing QC, et al. Radiation-induced liver disease: beyond DNA damage. Cell Cycle. 2023;22(5):506\u201326.","journal-title":"Cell Cycle"},{"issue":"2","key":"2166_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamaoncol.2024.5403","volume":"11","author":"LA Dawson","year":"2025","unstructured":"Dawson LA, Winter KA, Knox JJ, Zhu AX, Krishnan S, Guha C, et al. Stereotactic body radiotherapy vs sorafenib alone in hepatocellular carcinoma: the NRG Oncology\/RTOG 1112 phase 3 randomized clinical trial. JAMA Oncol. 2025;11(2):136\u201344.","journal-title":"JAMA Oncol"},{"key":"2166_CR12","doi-asserted-by":"publisher","first-page":"1193762","DOI":"10.3389\/fonc.2023.1193762","volume":"13","author":"AH Shannon","year":"2023","unstructured":"Shannon AH, Manne A, Pardo DAD, Pawlik TM. Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma. Front Oncol. 2023;13:1193762.","journal-title":"Front Oncol"},{"issue":"1","key":"2166_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3892\/ol.2025.15088","volume":"30","author":"C Ma","year":"2025","unstructured":"Ma C, Yu X, Zhang X, Su L, Jiang O, Cui R. Combination of radiotherapy and ICIs in advanced hepatocellular carcinoma: A systematic review of current evidence and future prospects. Oncol Lett. 2025;30(1):342.","journal-title":"Oncol Lett"},{"issue":"6","key":"2166_CR14","first-page":"590","volume":"13","author":"Y-G Song","year":"2024","unstructured":"Song Y-G, Yeom K-M, Jung E, Kim SG, Kim YS, Yoo J-J. Risk of bleeding in hepatocellular carcinoma patients treated with atezolizumab\/bevacizumab: a systematic review and meta-analysis. Liver Cancer. 2024;13(6):590\u2013600.","journal-title":"Liver Cancer"},{"issue":"7","key":"2166_CR15","doi-asserted-by":"publisher","first-page":"e922","DOI":"10.1093\/oncolo\/oyae048","volume":"29","author":"C-W Su","year":"2024","unstructured":"Su C-W, Teng W, Shen EY-L, Huang B-S, Lin P-T, Hou M-M, et al. Concurrent atezolizumab plus bevacizumab and high-dose external beam radiotherapy for highly advanced hepatocellular carcinoma. Oncologist. 2024;29(7):e922\u201331.","journal-title":"Oncologist"},{"key":"2166_CR16","doi-asserted-by":"publisher","first-page":"1643304","DOI":"10.3389\/fonc.2025.1643304","volume":"15","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Chen Y, Huang C, Liu M, Tong L, Tang W, et al. Efficacy and safety of radiotherapy combined with immunotherapy and targeted therapy versus immunotherapy plus targeted therapy alone in unresectable hepatocellular carcinoma: a retrospective study. Front Oncol. 2025;15:1643304.","journal-title":"Front Oncol"},{"issue":"2","key":"2166_CR17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jhep.2019.10.021","volume":"72","author":"B Sangro","year":"2020","unstructured":"Sangro B, Chan SL, Meyer T, Reig M, El-Khoueiry A, Galle PR. Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma. J Hepatol. 2020;72(2):320\u201341.","journal-title":"J Hepatol"},{"issue":"21","key":"2166_CR18","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.3390\/foods11213323","volume":"11","author":"S Bakrim","year":"2022","unstructured":"Bakrim S, El Omari N, El Hachlafi N, Bakri Y, Lee L-H, Bouyahya A. Dietary phenolic compounds as anticancer natural drugs: recent update on molecular mechanisms and clinical trials. Foods. 2022;11(21):3323.","journal-title":"Foods"},{"issue":"18","key":"2166_CR19","doi-asserted-by":"publisher","first-page":"10244","DOI":"10.3390\/ijms231810244","volume":"23","author":"AF Vladu","year":"2022","unstructured":"Vladu AF, Ficai D, Ene AG, Ficai A. Combination therapy using polyphenols: An efficient way to improve antitumoral activity and reduce resistance. Int J Mol Sci. 2022;23(18):10244.","journal-title":"Int J Mol Sci"},{"issue":"24","key":"2166_CR20","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.3390\/cancers14246203","volume":"14","author":"ST Asma","year":"2022","unstructured":"Asma ST, Acaroz U, Imre K, Morar A, Shah SRA, Hussain SZ, et al. Natural products\/bioactive compounds as a source of anticancer drugs. Cancers. 2022;14(24):6203.","journal-title":"Cancers"},{"issue":"20","key":"2166_CR21","doi-asserted-by":"publisher","first-page":"9972","DOI":"10.3390\/ijms26209972","volume":"26","author":"K Niska","year":"2025","unstructured":"Niska K, Bloch P, Kowalczyk PK, Zima K, Gramatyka M, Cicho\u0144 T, et al. Radioprotective Potential of a Polyphenol-Rich Extract Blend: Preclinical Evaluation in Female Balb\/c Mice Exposed to Ionizing Radiation. Int J Mol Sci. 2025;26(20):9972.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2166_CR22","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3390\/cancers15092412","volume":"15","author":"\u00c8 Prades-Sagarra","year":"2023","unstructured":"Prades-Sagarra \u00c8, Yaromina A, Dubois LJ. Polyphenols as potential protectors against radiation-induced adverse effects in patients with thoracic cancer. Cancers. 2023;15(9):2412.","journal-title":"Cancers"},{"issue":"9","key":"2166_CR23","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.3390\/pr11092771","volume":"11","author":"CMC Andr\u00e9s","year":"2023","unstructured":"Andr\u00e9s CMC, de la P\u00e9rez JM, Juan CA, Plou FJ, P\u00e9rez-Lebe\u00f1a E. Polyphenols as antioxidant\/pro-oxidant compounds and donors of reducing species: Relationship with human antioxidant metabolism. Processes. 2023;11(9):2771.","journal-title":"Processes"},{"issue":"7","key":"2166_CR24","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/metabo13070796","volume":"13","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Ye X, Xiong Z, Ihsan A, Ares I, Mart\u00ednez M, et al. Cancer metabolism: the role of ROS in DNA damage and induction of apoptosis in cancer cells. Metabolites. 2023;13(7):796.","journal-title":"Metabolites"},{"issue":"3","key":"2166_CR25","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/molecules25030596","volume":"25","author":"MC Villegas-Aguilar","year":"2020","unstructured":"Villegas-Aguilar MC, Fern\u00e1ndez-Ochoa \u00c1, C\u00e1diz-Gurrea MdlL, Pimentel-Moral S, Lozano-S\u00e1nchez J, Arr\u00e1ez-Rom\u00e1n D, et al. Pleiotropic biological effects of dietary phenolic compounds and their metabolites on energy metabolism, inflammation and aging. Molecules. 2020;25(3):596.","journal-title":"Molecules"},{"issue":"5","key":"2166_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/biom15050629","volume":"15","author":"ZSO Ahmed","year":"2025","unstructured":"Ahmed ZSO, Khan E, Elias N, Elshebiny A, Dou Q. Updated Review on Natural Polyphenols: Molecular Mechanisms, Biological Effects, and Clinical Applications for Cancer Management. Biomolecules. 2025;15(5):629.","journal-title":"Biomolecules"},{"issue":"6","key":"2166_CR27","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3390\/pharmaceutics15061612","volume":"15","author":"DL Pouliquen","year":"2023","unstructured":"Pouliquen DL, Tro\u0161elj KG, Anto RJ. Curcuminoids as anticancer drugs: pleiotropic effects, potential for metabolic reprogramming and prospects for the future. Pharmaceutics. 2023;15(6):1612.","journal-title":"Pharmaceutics"},{"issue":"8\u20139","key":"2166_CR28","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1351\/pac199567081307","volume":"67","author":"G Moss","year":"1995","unstructured":"Moss G, Smith P, Tavernier D. Glossary of class names of organic compounds and reactivity intermediates based on structure (IUPAC Recommendations 1995). Pure Appl Chem. 1995;67(8\u20139):1307\u201375.","journal-title":"Pure Appl Chem"},{"issue":"10","key":"2166_CR29","first-page":"1775","volume":"3","author":"J van Rijn","year":"1997","unstructured":"van Rijn J, van den Berg J. Flavonoids as enhancers of x-ray-induced cell damage in hepatoma cells. Clin cancer research: official J Am Association Cancer Res. 1997;3(10):1775\u20139.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"issue":"3","key":"2166_CR30","first-page":"229","volume":"15","author":"J Jang","year":"2017","unstructured":"Jang J, Kang M, Lim Y, Kim J, Kim J. Effects of quercetin on ionizing radiation-induced cellular responses in HepG2 cells. Int J Radiation Res. 2017;15(3):229\u201339.","journal-title":"Int J Radiation Res"},{"key":"2166_CR31","doi-asserted-by":"publisher","first-page":"0164","DOI":"10.34133\/bmr.0164","volume":"29","author":"Q Du","year":"2025","unstructured":"Du Q, Jiang H, Wu D, Song C, Hu W, Lu Q, et al. Radiation-Activated Cobalt-Based Zeolite Imidazolate Frameworks for Tumor Multitherapy. Biomaterials Res. 2025;29:0164.","journal-title":"Biomaterials Res"},{"issue":"4","key":"2166_CR32","doi-asserted-by":"publisher","first-page":"833","DOI":"10.17305\/bb.2024.11125","volume":"25","author":"N Bedolla","year":"2025","unstructured":"Bedolla N, Liu L, Xie Q, Liu X, Ren Y. Quercetin regulates sensitivity to X-ray radiation of hepatocellular carcinoma through miR-216a-3p. Biomolecules Biomed. 2025;25(4):833.","journal-title":"Biomolecules Biomed"},{"issue":"5","key":"2166_CR33","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1016\/j.jhep.2023.10.036","volume":"80","author":"T Shao","year":"2024","unstructured":"Shao T, Chen Y-L. Stop using the misidentified cell line LO2 as a human hepatocyte. J Hepatol. 2024;80(5):e200\u20131.","journal-title":"J Hepatol"},{"issue":"3","key":"2166_CR34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1667\/RR15380.1","volume":"193","author":"H Yan","year":"2020","unstructured":"Yan H, Jiang J, Du A, Gao J, Zhang D, Song L. Genistein enhances radiosensitivity of human hepatocellular carcinoma cells by inducing G2\/M arrest and apoptosis. Radiat Res. 2020;193(3):286\u2013300.","journal-title":"Radiat Res"},{"issue":"10","key":"2166_CR35","doi-asserted-by":"publisher","first-page":"9076","DOI":"10.3390\/ijms24109076","volume":"24","author":"TW Kim","year":"2023","unstructured":"Kim TW. Fisetin, an anti-inflammatory agent, overcomes radioresistance by activating the PERK-ATF4-CHOP axis in liver cancer. Int J Mol Sci. 2023;24(10):9076.","journal-title":"Int J Mol Sci"},{"key":"2166_CR36","doi-asserted-by":"publisher","first-page":"114740","DOI":"10.1016\/j.intimp.2025.114740","volume":"157","author":"X Xu","year":"2025","unstructured":"Xu X, Cheng Y, Yang Z, Yin Y, Qian Y, Yang H, et al. Wogonin potentiates the irradiation effect on hepatocellular carcinoma by activating the Hippo-Yes-associated protein\/transcriptional co-activator with PDZ-binding motif pathway. Int Immunopharmacol. 2025;157:114740.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"2166_CR37","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1096\/fj.14-266718","volume":"29","author":"F Ye","year":"2015","unstructured":"Ye F, Chen C, Qin J, Liu J, Zheng C. Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China. FASEB J. 2015;29(10):4268\u201372.","journal-title":"FASEB J"},{"issue":"4","key":"2166_CR38","first-page":"1368","volume":"5","author":"C Sun","year":"2015","unstructured":"Sun C, Wang Z-H, Liu X-X, Yang L-N, Wang Y, Liu Y, et al. Disturbance of redox status enhances radiosensitivity of hepatocellular carcinoma. Am J cancer Res. 2015;5(4):1368.","journal-title":"Am J cancer Res"},{"issue":"5","key":"2166_CR39","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41419-018-0575-0","volume":"9","author":"C-C Chen","year":"2018","unstructured":"Chen C-C, Chen C-Y, Ueng S-H, Hsueh C, Yeh C-T, Ho J-Y, et al. Corylin increases the sensitivity of hepatocellular carcinoma cells to chemotherapy through long noncoding RNA RAD51-AS1-mediated inhibition of DNA repair. Cell Death Dis. 2018;9(5):543.","journal-title":"Cell Death Dis"},{"key":"2166_CR40","doi-asserted-by":"publisher","first-page":"110807","DOI":"10.1016\/j.fct.2019.110807","volume":"133","author":"Q Kang","year":"2019","unstructured":"Kang Q, Zhang X, Cao N, Chen C, Yi J, Hao L, et al. EGCG enhances cancer cells sensitivity under 60Co\u03b3 radiation based on miR-34a\/Sirt1\/p53. Food Chem Toxicol. 2019;133:110807.","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"2166_CR41","doi-asserted-by":"publisher","first-page":"14043","DOI":"10.1038\/s41598-017-14211-4","volume":"7","author":"U Das","year":"2017","unstructured":"Das U, Biswas S, Chattopadhyay S, Chakraborty A, Dey Sharma R, Banerji A, et al. Radiosensitizing effect of ellagic acid on growth of Hepatocellular carcinoma cells: an in vitro study. Sci Rep. 2017;7(1):14043.","journal-title":"Sci Rep"},{"issue":"9\u201310","key":"2166_CR42","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1080\/10715762.2019.1655559","volume":"53","author":"U Das","year":"2019","unstructured":"Das U, Manna K, Adhikary A, Mishra S, Saha KD, Sharma RD, et al. Ferulic acid enhances the radiation sensitivity of lung and liver carcinoma cells by collapsing redox homeostasis: mechanistic involvement of Akt\/p38 MAPK signalling pathway. Free Radic Res. 2019;53(9\u201310):944\u201367.","journal-title":"Free Radic Res"},{"issue":"1","key":"2166_CR43","doi-asserted-by":"publisher","first-page":"4566949","DOI":"10.1155\/2022\/4566949","volume":"2022","author":"X Yin","year":"2022","unstructured":"Yin X, He X, Wu L, Yan D, Yan S. Chlorogenic Acid, the Main Antioxidant in Coffee, Reduces Radiation-Induced Apoptosis and DNA Damage via NF\u2010E2\u2010Related Factor 2 (Nrf2) Activation in Hepatocellular Carcinoma. Oxidative Med Cell Longev. 2022;2022(1):4566949.","journal-title":"Oxidative Med Cell Longev"},{"issue":"1","key":"2166_CR44","first-page":"258425","volume":"2013","author":"C-M Lee","year":"2013","unstructured":"Lee C-M, Su Y-H, Huynh T-T, Lee W-H, Chiou J-F, Lin Y-K, et al. BlueBerry isolate, pterostilbene, functions as a potential anticancer stem cell agent in suppressing irradiation-mediated enrichment of hepatoma stem cells. Evidence\u2010Based Complement Altern Med. 2013;2013(1):258425.","journal-title":"Evidence\u2010Based Complement Altern Med"},{"issue":"5","key":"2166_CR45","first-page":"2931","volume":"11","author":"Y Tai","year":"2018","unstructured":"Tai Y, Gao J-H, Zhao C, Tong H, Zheng S-P, Huang Z-Y, et al. SK-Hep1: not hepatocellular carcinoma cells but a cell model for liver sinusoidal endothelial cells. Int J Clin Exp Pathol. 2018;11(5):2931.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"2166_CR46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1269\/jrr.11062","volume":"53","author":"Y Xie","year":"2012","unstructured":"Xie Y, Zhang J, Xu Y, Shao C. SirT1 confers hypoxia-induced radioresistance via the modulation of c-Myc stabilization on hepatoma cells. J Radiat Res. 2012;53(1):44\u201350.","journal-title":"J Radiat Res"},{"issue":"4","key":"2166_CR47","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.21873\/invivo.11973","volume":"34","author":"Y-S Chen","year":"2020","unstructured":"Chen Y-S, Sun R, Chen W-L, Yau Y-C, Hsu F-T, Chung J-G, et al. The in vivo radiosensitizing effect of magnolol on tumor growth of hepatocellular carcinoma. vivo. 2020;34(4):1789\u201396.","journal-title":"vivo"},{"issue":"7","key":"2166_CR48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00066-011-2248-0","volume":"187","author":"M Str\u00f6fer","year":"2011","unstructured":"Str\u00f6fer M, Jelkmann W, Depping R. Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF. Strahlenther Onkol. 2011;187(7):393\u2013400.","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"2166_CR49","first-page":"363671","volume":"2015","author":"F-T Hsu","year":"2015","unstructured":"Hsu F-T, Liu Y-C, Liu T-T, Hwang J-J. Curcumin sensitizes hepatocellular carcinoma cells to radiation via suppression of radiation-induced NF\u2010\u03baB activity. Biomed Res Int. 2015;2015(1):363671.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2166_CR50","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13046-025-03477-6","volume":"44","author":"J Liu","year":"2025","unstructured":"Liu J, Zhang X, Fan X, Liu P, Mi Z, Tan H, et al. Liensinine reshapes the immune microenvironment and enhances immunotherapy by reprogramming metabolism through the AMPK-HIF-1\u03b1 axis in hepatocellular carcinoma. J Experimental Clin Cancer Res. 2025;44(1):208.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"4","key":"2166_CR51","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3892\/or.2015.3744","volume":"33","author":"SY Hwang","year":"2015","unstructured":"Hwang SY, Heo K, Kim JS, Im JW, Lee SM, Cho M, et al. Emodin attenuates radioresistance induced by hypoxia in HepG2 cells via the enhancement of PARP1 cleavage and inhibition of JMJD2B. Oncol Rep. 2015;33(4):1691\u20138.","journal-title":"Oncol Rep"},{"issue":"4","key":"2166_CR52","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ddr.21914","volume":"83","author":"L Sun","year":"2022","unstructured":"Sun L, Cai H, Zhou T, Xiang H, Long L. Verbascoside enhances radiosensitivity of hepatocellular carcinoma cells through regulating miR-101\u20103p\/Wee1 axis. Drug Dev Res. 2022;83(4):891\u20139.","journal-title":"Drug Dev Res"},{"key":"2166_CR53","doi-asserted-by":"publisher","first-page":"109326","DOI":"10.1016\/j.radphyschem.2020.109326","volume":"181","author":"X Zhang","year":"2021","unstructured":"Zhang X, Kang Q, Ji Z, Hao L, Wang T, Zhu J, et al. Radiosensitization potential of caffeic acid phenethyl ester and the long non-coding RNAs in response to 60Co\u03b3 radiation in mouse hepatoma cells. Radiat Phys Chem. 2021;181:109326.","journal-title":"Radiat Phys Chem"},{"key":"2166_CR54","doi-asserted-by":"crossref","unstructured":"Mauro E, de Castro T, Zeitlhoefler M, Sung MW, Villanueva A, Mazzaferro V et al. Hepatocellular Carcinoma: Epidemiology, diagnosis and treatment. JHEP Rep. 2025:101571.","DOI":"10.1016\/j.jhepr.2025.101571"},{"issue":"10","key":"2166_CR55","doi-asserted-by":"publisher","first-page":"39800","DOI":"10.31083\/FBL39800","volume":"30","author":"A Verdina","year":"2025","unstructured":"Verdina A, D\u2019Orazi G. Ionizing Radiation in Clinical Diagnostics and Radiotherapy: The Dual Role of NRF2 in Cell Protection and Carcinogenesis. Front Bioscience-Landmark. 2025;30(10):39800.","journal-title":"Front Bioscience-Landmark"},{"issue":"1","key":"2166_CR56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13277-012-0545-6","volume":"34","author":"VR Bandugula","year":"2013","unstructured":"Bandugula VR. 2-Deoxy-D-glucose and ferulic acid modulates radiation response signaling in non-small cell lung cancer cells. Tumor Biology. 2013;34(1):251\u20139.","journal-title":"Tumor Biology"},{"issue":"7","key":"2166_CR57","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.tiv.2011.05.007","volume":"25","author":"S Karthikeyan","year":"2011","unstructured":"Karthikeyan S, Kanimozhi G, Prasad NR, Mahalakshmi R. Radiosensitizing effect of ferulic acid on human cervical carcinoma cells in vitro. Toxicol In Vitro. 2011;25(7):1366\u201375.","journal-title":"Toxicol In Vitro"},{"issue":"6","key":"2166_CR58","first-page":"644","volume":"37","author":"L Ming","year":"2019","unstructured":"Ming L, Jun W, Li L, Zhong-xia C. Eucommia chlorogenic acid enhances the radiosensitivity of retinoblastoma cell line HXO-Rb44 via PI3K\/AKT\/Nrf-2 pathway. Chin J Clin Anat. 2019;37(6):644\u20139.","journal-title":"Chin J Clin Anat"},{"issue":"22","key":"2166_CR59","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1038\/onc.2012.294","volume":"32","author":"Y Pan","year":"2013","unstructured":"Pan Y, Zhang Q, Atsaves V, Yang H, Claret FX. Suppression of Jab1\/CSN5 induces radio-and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways. Oncogene. 2013;32(22):2756\u201366.","journal-title":"Oncogene"},{"issue":"11\u201312","key":"2166_CR60","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.bbagrm.2012.10.001","volume":"1819","author":"J-G Kim","year":"2012","unstructured":"Kim J-G, Yi JM, Park S-J, Kim J-S, Son TG, Yang K, et al. Histone demethylase JMJD2B-mediated cell proliferation regulated by hypoxia and radiation in gastric cancer cell. Biochim et Biophys Acta (BBA)-Gene Regul Mech. 2012;1819(11\u201312):1200\u20137.","journal-title":"Biochim et Biophys Acta (BBA)-Gene Regul Mech"},{"issue":"7","key":"2166_CR61","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1158\/1078-0432.CCR-04-1582","volume":"11","author":"B Bucci","year":"2005","unstructured":"Bucci B, D\u2019Agnano I, Amendola D, Citti A, Raza GH, Miceli R, et al. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins. Clin Cancer Res. 2005;11(7):2756\u201367.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2166_CR62","doi-asserted-by":"publisher","first-page":"27346","DOI":"10.1038\/srep27346","volume":"6","author":"A Mao","year":"2016","unstructured":"Mao A, Zhao Q, Zhou X, Sun C, Si J, Zhou R, et al. MicroRNA-449a enhances radiosensitivity by downregulation of c-Myc in prostate cancer cells. Sci Rep. 2016;6(1):27346.","journal-title":"Sci Rep"},{"issue":"15","key":"2166_CR63","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.18632\/oncotarget.2176","volume":"5","author":"R Wang","year":"2014","unstructured":"Wang R, Chen D-Q, Huang J-Y, Zhang K, Feng B, Pan B-Z, et al. Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451\/c-Myc-survivin\/rad-51 signaling. Oncotarget. 2014;5(15):6113.","journal-title":"Oncotarget"},{"issue":"21","key":"2166_CR64","doi-asserted-by":"publisher","first-page":"8748","DOI":"10.1158\/0008-5472.CAN-10-0944","volume":"70","author":"KR Luoto","year":"2010","unstructured":"Luoto KR, Meng AX, Wasylishen AR, Zhao H, Coackley CL, Penn LZ, et al. Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair. Cancer Res. 2010;70(21):8748\u201359.","journal-title":"Cancer Res"},{"issue":"10","key":"2166_CR65","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","volume":"40","author":"D L\u00f3pez-Terrada","year":"2009","unstructured":"L\u00f3pez-Terrada D, Cheung SW, Finegold MJ, Knowles BB. Hep G2 is a hepatoblastoma-derived cell line. Hum Pathol. 2009;40(10):1512.","journal-title":"Hum Pathol"},{"issue":"23","key":"2166_CR66","doi-asserted-by":"publisher","first-page":"13135","DOI":"10.3390\/ijms222313135","volume":"22","author":"VA Arzumanian","year":"2021","unstructured":"Arzumanian VA, Kiseleva OI, Poverennaya EV. The curious case of the HepG2 cell line: 40 years of expertise. Int J Mol Sci. 2021;22(23):13135.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2166_CR67","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/antiox9100923","volume":"9","author":"J Grgi\u0107","year":"2020","unstructured":"Grgi\u0107 J, \u0160elo G, Planini\u0107 M, Ti\u0161ma M, Buci\u0107-Koji\u0107 A. Role of the encapsulation in bioavailability of phenolic compounds. Antioxidants. 2020;9(10):923.","journal-title":"Antioxidants"},{"issue":"12","key":"2166_CR68","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1080\/10408398.2024.2336051","volume":"65","author":"M Tomas","year":"2025","unstructured":"Tomas M, Wen Y, Liao W, Zhang L, Zhao C, McClements DJ, et al. Recent progress in promoting the bioavailability of polyphenols in plant-based foods. Crit Rev Food Sci Nutr. 2025;65(12):2343\u201364.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2166_CR69","doi-asserted-by":"publisher","first-page":"102771","DOI":"10.1016\/j.nantod.2025.102771","volume":"63","author":"Z Lei","year":"2025","unstructured":"Lei Z, Liao J, Yao H, Zhou X, Yang C, Wang Q, et al. Microenvironment-triggered copper peroxide and tannic acid cooperatively iron-coordinated nanocomposites for oxidative stress-enhanced radiotherapy of hepatocellular carcinoma. Nano Today. 2025;63:102771.","journal-title":"Nano Today"},{"issue":"29","key":"2166_CR70","doi-asserted-by":"publisher","first-page":"2401222","DOI":"10.1002\/adma.202401222","volume":"36","author":"D Wang","year":"2024","unstructured":"Wang D, Jia H, Cao H, Hou X, Wang Q, Lin J, et al. A Dual-Channel Ca2\u2009+\u2009Nanomodulator Induces Intracellular Ca2\u2009+\u2009Disorders via Endogenous Ca2\u2009+\u2009Redistribution for Tumor Radiosensitization. Adv Mater. 2024;36(29):2401222.","journal-title":"Adv Mater"},{"key":"2166_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2025.01.088","volume":"380","author":"Y Peng","year":"2025","unstructured":"Peng Y, Liu H, Liang X, Cao L, Teng M, Chen H, et al. Self-assembling chemodrug fiber-hydrogel for transarterial chemoembolization and radiotherapy-enhanced antitumor immunity. J Controlled Release. 2025;380:1\u201316.","journal-title":"J Controlled Release"},{"key":"2166_CR72","doi-asserted-by":"publisher","first-page":"110620","DOI":"10.1016\/j.biopha.2020.110620","volume":"131","author":"ME Abdraboh","year":"2020","unstructured":"Abdraboh ME, Essa ZS, Abdelrazzak AB, El-Far YM, Elsherbini Y, El-Zayat MM, et al. Radio-sensitizing effect of a cocktail of phytochemicals on HepG2 cell proliferation, motility and survival. Biomed Pharmacother. 2020;131:110620.","journal-title":"Biomed Pharmacother"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02166-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02166-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02166-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:07:39Z","timestamp":1783386459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02166-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2166"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02166-8","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Data availability"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent participate."}}],"article-number":"251"}}